Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from GE Healthcare Technologies Inc ( (GEHC) ) is now available.
On March 13, 2026, GE HealthCare Technologies Inc. appointed Kevin A. Lobo to its Board of Directors, with his term running until the 2026 Annual Meeting of Stockholders, and named him to the Talent, Culture, and Compensation Committee, with compensation and indemnification aligned to the company’s existing non-employee director framework. The company noted there were no special arrangements or related-party transactions tied to his selection, while directors Risa Lavizzo-Mourey and Tomislav Mihaljevic informed the Board on the same date that they would not stand for re-election in 2026 due to other commitments, and on March 17, 2026, GE HealthCare issued a press release formalizing these board changes, which were not attributed to any disagreements over corporate operations or policies.
The most recent analyst rating on (GEHC) stock is a Buy with a $79.00 price target. To see the full list of analyst forecasts on GE Healthcare Technologies Inc stock, see the GEHC Stock Forecast page.
Spark’s Take on GEHC Stock
According to Spark, TipRanks’ AI Analyst, GEHC is a Neutral.
The score is driven primarily by mixed financial performance—especially the 2025 cash flow deterioration—offset by a stronger balance sheet and supportive 2026 guidance for growth, margins, and free cash flow. Technicals are neutral with negative MACD, and valuation appears reasonable but not notably attractive given the low dividend yield.
To see Spark’s full report on GEHC stock, click here.
More about GE Healthcare Technologies Inc
GE HealthCare Technologies Inc. is a medical technology and diagnostics company that provides imaging, monitoring, and other healthcare equipment and solutions to hospitals, clinics, and healthcare systems worldwide. The company operates in the global healthcare sector, focusing on technologies that support clinical decision-making and patient care across multiple therapeutic areas.
Average Trading Volume: 3,339,632
Technical Sentiment Signal: Sell
Current Market Cap: $32.89B
See more insights into GEHC stock on TipRanks’ Stock Analysis page.